Texas Yale Capital Corp’s Sanofi SNY Stock Holding History

Texas Yale Capital Corp’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,555	Closed	-$205K	–	473
2024 Q3	$205K	Buy	+3,555	New	+$192K	0.01%	437
2023 Q1	–	Sell	-5,555	Closed	-$269K	–	468
2022 Q4	$269K	Hold	5,555	–	–	0.02%	391
2022 Q3	$211K	Hold	5,555	–	–	0.01%	407
2022 Q2	$278K	Hold	5,555	–	–	0.02%	372
2022 Q1	$285K	Hold	5,555	–	–	0.02%	379
2021 Q4	$278K	Hold	5,555	–	–	0.01%	380
2021 Q3	$268K	Hold	5,555	–	–	0.02%	385
2021 Q2	$293K	Hold	5,555	–	–	0.02%	375
2021 Q1	$275K	Hold	5,555	–	–	0.02%	377
2020 Q4	$270K	Hold	5,555	–	–	0.02%	377
2020 Q3	$279K	Hold	5,555	–	–	0.02%	361
2020 Q2	$284K	Buy	+5,555	New	+$270K	0.02%	356
2014 Q4	–	Sell	-5,279	Closed	-$298K	–	484
2014 Q3	$298K	Buy	+5,279	New	+$284K	0.03%	369

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Texas Yale Capital Corp's SNY Position: Q4 2024 in Review

Texas Yale Capital Corp sold out of Sanofi (SNY) in Q4 2024, closing a stake of 3,555 shares — an estimated $205K sold.

Texas Yale Capital Corp first reported a position in SNY in Q3 2014 and held it in 13 quarters. The position peaked at $298K in Q3 2014. 732 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

Texas Yale Capital Corp reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
Texas Yale Capital Corp sold 3,555 Sanofi shares in Q4 2024, an estimated $205K.
Texas Yale Capital Corp first reported a position in Sanofi in Q3 2014 and held it in 13 quarters.
Texas Yale Capital Corp's Sanofi position peaked at $298K in Q3 2014.
732 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Texas Yale Capital Corp's 13F filing for Q4 2024, filed 13 Feb 2025.